Niramai expands its presence, launches screening facility in Kerala

Bengaluru: The first installation of Niramai’s Artificial Intelligence-based Thermalytix solution for early detection of breast cancer was launched in Kerala on Friday 16 September 2022.

The Founder and Chief Executive Officer of NIRAMAI Health Analytix Dr. Geetha Manjunath who developed this innovative technology inaugurated the 1st Center in Kerala at Keyhole Clinic, Edapally, Kochi along with leading doctors from Kerala, Dr R Padmakumar, Dr Madhukar Pai, Dr Arun Warrier, Dr Maria Varghese and Dr Mabel V Periera.

Breast Cancer is the leading cause of cancer deaths in women today. One in 17 women develop some form of breast problems in their lifetime and early detection is the key to survival. Niramai has developed a novel artificial intelligence based medical device to detect breast cancer at a much earlier stage than traditional methods or self-examination.

Niramai’s innovative solution called ‘Thermalytix’, is an automated breast health screening and diagnostic tool, which combines thermal imaging with artificial intelligence. NIRAMAI Thermalytix test can be done for women of 18 years and above. It is privacy-sensitive, non-invasive, radiation-free, and has high accuracy which can detect the minutest of lumps or other abnormalities. Women can avail this service with a prior appointment.

Dr. Geetha Manjunath, Founder & CEO, Niramai Health Analytix, added, “We are excited to partner with Keyhole Clinic to take our clinically proven Thermalytix screening service to many more women in Kerala and help save lives. We are also conducting many free programmes to raise awareness amongst women about early detection of breast cancer and educating the masses on the importance of frequent checks.”

Dr R Padmakumar, CMD of Keyhole Clinic, said, “We are committed to offering the best healthcare services to the general public. Collaborating with an innovative company like Niramai to offer early-stage breast screening will surely be beneficial to our patients.” Discounts for Niramai Breast screening in the month of September in connection with the launch and in October in connection with Breast Cancer Awareness Month was also announced by the team.

A CME on this novel technology was held during the occasion to learn more about this unique modality and how its no-touch, no-see, and no-radiation screening can encourage women of all ages to get tested. Dr R Padmakumar, Dr Madhukar Pai, Dr Arun Warrier, Dr Maria Varghese and Dr Mabel V Periera who chaired the CME spoke on the occasion and appreciated the efforts of Niramai in developing this technology which can save many lives.